Home › Funds › Samsara BioCapital, LLC › NKTX

Samsara BioCapital, LLC position in NKTX

NKARTA INC · Health Care

Samsara BioCapital, LLC reported holding 3,507,666 shares of NKTX (NKARTA INC) in its Q3 2026 13F filing — a position valued at US$9.2M, representing 0.87% of its reported portfolio and ranking #17 among its reported holdings. Samsara BioCapital, LLC has disclosed NKTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.51M sh
Reported value held$9.19M
Portfolio Weight0.87%
First reportedQ3 2023
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Samsara BioCapital, LLC's NKTX position evolved

Samsara BioCapital, LLC first disclosed a stake in NKTX in Q3 2023 at 2,868,035 shares (US$4.0M). The position peaked in Q1 2024 at 3,768,035 shares, worth US$40.7M. Across 13 filings, Samsara BioCapital, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 3,507,666 shares valued at US$9.2M. Notable position changes include a 31% increase in Q1 2024 (shares fell 45% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.87M $3.99M New
Q4 2023 2.87M $18.93M Hold
Q1 2024 3.77M $40.73M Add
Q2 2024 3.77M $22.27M Hold
Q3 2024 3.77M $17.03M Hold
Q4 2024 3.77M $9.38M Hold
Q1 2025 3.77M $6.93M Hold
Q2 2025 3.77M $6.25M Hold
Q3 2025 3.77M $7.80M Hold
Q4 2025 3.51M $6.49M Reduce
Q1 2026 3.51M $7.40M Hold
Q2 2026 3.51M $9.93M Hold
Q3 2026 3.51M $9.19M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NKTX and 13F data

NKTX (NKARTA INC) is a Health Care company. 24 other funds we track also report a position in NKTX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$28.3M), NEA Management Company, LLC (US$9.4M), SR ONE CAPITAL MANAGEMENT, LP (US$8.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NKTX

All NKTX fund holders →

FAQ

How long has Samsara BioCapital, LLC held NKTX?

Samsara BioCapital, LLC has disclosed NKTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Samsara BioCapital, LLC's current position in NKTX?

As of Q3 2026, Samsara BioCapital, LLC holds 3.51M shares of NKTX (NKARTA INC), valued at $9.19M, representing 0.87% of its reported portfolio and ranking #17.

Has Samsara BioCapital, LLC been buying or selling NKTX?

In the latest 13F filing (Q3 2026), Samsara BioCapital, LLC held unchanged its position in NKTX. The position peaked in Q1 2024 at 3.77M shares.

Which other funds hold NKTX?

Other major institutional holders of NKTX include RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.